N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide

C80H89F3N18O11 — CID 155449105

IUPACN-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide
SMILESCOc1cc2nn([C@@H]3CC[C@@H](CN4CCC(c5cccc6c5n(C)c(=O)n6C5CCC(=O)NC5=O)CC4)C(C4C[C@H](n5cc6cc(NC(=O)c7cccc(C(F)(F)F)n7)c(OCCO)cc6n5)CC[C@H]4CN(C)C4CCN(c5cccc6c5n(C)c(=O)n6C5CCC(=O)NC5=O)CC4)C3)cc2cc1NC(=O)c1cncnc1
InChIInChI=1S/C80H89F3N18O11/c1-93(51-24-28-97(29-25-51)62-10-7-12-64-73(62)95(3)79(110)101(64)66-19-21-71(104)90-77(66)108)40-46-14-16-52(99-43-49-33-61(68(112-31-30-102)37-59(49)92-99)88-75(106)57-9-6-13-69(86-57)80(81,82)83)34-55(46)56-35-53(98-42-48-32-60(67(111-4)36-58(48)91-98)87-74(105)50-38-84-44-85-39-50)17-15-47(56)41-96-26-22-45(23-27-96)54-8-5-11-63-72(54)94(2)78(109)100(63)65-18-20-70(103)89-76(65)107/h5-13,32-33,36-39,42-47,51-53,55-56,65-66,102H,14-31,34-35,40-41H2,1-4H3,(H,87,105)(H,88,106)(H,89,103,107)(H,90,104,108)/t46-,47-,52+,53+,55?,56?,65?,66?/m0/s1
InChIKeyJAPNOHCBZZHKIQ-QRZZDMLNSA-N
MW1535.70 g/mol
LogP8.83
Rot. Bonds20

About N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide

N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide (PubChem CID 155449105) has the molecular formula C80H89F3N18O11 and a molecular weight of 1535.70 g/mol. Its IUPAC name is N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide.

Molecular Properties

Compound NameN-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide
PubChem CID155449105
Molecular FormulaC80H89F3N18O11
Molecular Weight1535.70 g/mol
Exact Mass1534.69
IUPAC NameN-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide
SMILESCOc1cc2nn([C@@H]3CC[C@@H](CN4CCC(c5cccc6c5n(C)c(=O)n6C5CCC(=O)NC5=O)CC4)C(C4C[C@H](n5cc6cc(NC(=O)c7cccc(C(F)(F)F)n7)c(OCCO)cc6n5)CC[C@H]4CN(C)C4CCN(c5cccc6c5n(C)c(=O)n6C5CCC(=O)NC5=O)CC4)C3)cc2cc1NC(=O)c1cncnc1
InChIInChI=1S/C80H89F3N18O11/c1-93(51-24-28-97(29-25-51)62-10-7-12-64-73(62)95(3)79(110)101(64)66-19-21-71(104)90-77(66)108)40-46-14-16-52(99-43-49-33-61(68(112-31-30-102)37-59(49)92-99)88-75(106)57-9-6-13-69(86-57)80(81,82)83)34-55(46)56-35-53(98-42-48-32-60(67(111-4)36-58(48)91-98)87-74(105)50-38-84-44-85-39-50)17-15-47(56)41-96-26-22-45(23-27-96)54-8-5-11-63-72(54)94(2)78(109)100(63)65-18-20-70(103)89-76(65)107/h5-13,32-33,36-39,42-47,51-53,55-56,65-66,102H,14-31,34-35,40-41H2,1-4H3,(H,87,105)(H,88,106)(H,89,103,107)(H,90,104,108)/t46-,47-,52+,53+,55?,56?,65?,66?/m0/s1
InChIKeyJAPNOHCBZZHKIQ-QRZZDMLNSA-N
XLogP8.83
TPSA327.12 Ų
H-Bond Donors5
H-Bond Acceptors25
Rotatable Bonds20
Heavy Atoms112
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001535.70
LogP ≤ 58.83
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide?
The IUPAC name of N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide (CID 155449105) is N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide.
What is the SMILES notation for N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide?
The canonical SMILES for N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide is COc1cc2nn([C@@H]3CC[C@@H](CN4CCC(c5cccc6c5n(C)c(=O)n6C5CCC(=O)NC5=O)CC4)C(C4C[C@H](n5cc6cc(NC(=O)c7cccc(C(F)(F)F)n7)c(OCCO)cc6n5)CC[C@H]4CN(C)C4CCN(c5cccc6c5n(C)c(=O)n6C5CCC(=O)NC5=O)CC4)C3)cc2cc1NC(=O)c1cncnc1.
What is the InChIKey of N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide?
The InChIKey is JAPNOHCBZZHKIQ-QRZZDMLNSA-N. The full InChI is InChI=1S/C80H89F3N18O11/c1-93(51-24-28-97(29-25-51)62-10-7-12-64-73(62)95(3)79(110)101(64)66-19-21-71(104)90-77(66)108)40-46-14-16-52(99-43-49-33-61(68(112-31-30-102)37-59(49)92-99)88-75(106)57-9-6-13-69(86-57)80(81,82)83)34-55(46)56-35-53(98-42-48-32-60(67(111-4)36-58(48)91-98)87-74(105)50-38-84-44-85-39-50)17-15-47(56)41-96-26-22-45(23-27-96)54-8-5-11-63-72(54)94(2)78(109)100(63)65-18-20-70(103)89-76(65)107/h5-13,32-33,36-39,42-47,51-53,55-56,65-66,102H,14-31,34-35,40-41H2,1-4H3,(H,87,105)(H,88,106)(H,89,103,107)(H,90,104,108)/t46-,47-,52+,53+,55?,56?,65?,66?/m0/s1.
What are the key properties of N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide?
N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide has a molecular weight of 1535.70 g/mol, XLogP of 8.83, 20 rotatable bonds, 5 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide is sourced from PubChem (CID 155449105), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).